Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Baby formula crunch in U.S. forces scramble to boost supplies

Published 06/16/2022, 12:21 PM
Updated 06/16/2022, 12:26 PM
© Reuters. FILE PHOTO: Empty shelves show a shortage of baby formula at a Target store in San Antonio, Texas, U.S. May 10, 2022.  REUTERS/Kaylee Greenlee Beal/File Photo

© Reuters. FILE PHOTO: Empty shelves show a shortage of baby formula at a Target store in San Antonio, Texas, U.S. May 10, 2022. REUTERS/Kaylee Greenlee Beal/File Photo

(Reuters) - Abbott Laboratories (NYSE:ABT) said it had halted production of EleCare baby formula at its Michigan plant after storms caused heavy flooding, in the latest setback for the recently re-opened factory that has been at the center of an infant formula shortage in the United States.

Top infant formula makers, including Reckitt Benckiser, Nestle and Danone SA (OTC:DANOY), have been shipping supplies from overseas since the United States temporarily allowed foreign imports from other suppliers.

Here is a timeline on how the baby formula crisis unfolded and the measures taken so far to resolve it:

Feb. 17

Abbott recalls dozens of types of powdered baby formulas, including Similac, Alimentum and EleCare, made at its Sturgis, Michigan plant after four consumers complained about bacterial infections in infants who had consumed those products; Recalled products had an expiry date of April 1, 2022 or later.

Feb. 21

China's custom officials warn consumers against buying and consuming certain of Abbott's infant and baby products.

Feb. 28

Abbott expands recall to include some Similac PM 60/40 products based on a fifth complaint of a bacterial infection.

March 4

House Appropriations Committee Chairwoman Rosa DeLauro asks for an investigation https://delauro.house.gov/media-center/press-releases/chair-delauro-requests-investigation-fda-handling-abbott-powdered-infant into the FDA's handling of the Abbott recall.

March 22

FDA probe of Abbott's Michigan facility finds a harmful bacteria called Cronobacter sakazakii on the surface of some areas near infant formula production, and reveals Abbott did not have a control system in place to prevent microbe contamination.

April 20

Abbott, calling the recall a "short-term hindrance", cuts its full-year sales growth forecast but maintains profit estimate.

April 28

House Appropriations Committee Chair Rosa DeLauro in a testimony submits a report acquired from a whistleblower, who had worked at the Abbott facility and had filed a complaint with the FDA in September 2021.

April 29

Abbott says it will release some nutrition products made at its Michigan plant on a case-by-case basis.

May 10

Major U.S. retailers including Target Corp (NYSE:TGT), CVS Health Corp (NYSE:CVS), Walgreens Boots Alliance (NASDAQ:WBA) and Kroger (NYSE:KR) Co place purchase limits on infant formula products.

Abbott says it has been prioritizing production of formula at other plants, and shipping formula from its Ireland facility.

May 12

President Joe Biden meets with executives from baby formula manufacturers and retailers including Target, Walmart (NYSE:WMT) and Nestle's Gerber to address the shortage.

May 13

Store-brand baby formula maker Perrigo Co (NYSE:PRGO) says shortages and heightened demand may last for the rest of the year.

U.S. Centers for Disease Control and Prevention (CDC) closes its investigation on Abbott, while Abbott says it has air shipped millions of cans of baby formula powder into the United States from its facility in Ireland.

May 16

The FDA says the United States will allow imports of infant formula from foreign makers that do not usually sell their products in the country.

Abbott reaches an agreement with the FDA on the steps needed to resume production at its Michigan plant.

May 17

U.S. House Democrats unveils a bill to provide $28 million in emergency funds to the FDA to help it respond to the shortage and bolster supervision of the industry.

Nestle SA (SIX:NESN) tells Reuters it was flying supplies to the United States from the Netherlands and Switzerland. Reckitt Benckiser, the second largest U.S. milk formula supplier, is boosting baby formula production by about 30%.

May 18

U.S. President Joe Biden invokes the Defense Production Act to help manufacturers obtain the ingredients needed to ramp up supply.

May 20

French baby formula maker Danone SA ramps up shipments of infant formula from Europe to the United States, according to U.S. customs data and shipping consultancy Ocean Audit.

May 24

Abbott says it plans to restart production at the facility on June 4.

The U.S. Federal Trade Commission launches an inquiry into the ongoing shortage and to examine past M&A deals in the formula market to understand their impact.

May 25

Danone says it has been doubling shipments of Neocate formula to the United States, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage.

Lawmakers grill FDA officials over what they called a lack of urgency in the agency's response to complaints about possible baby formula contamination at Abbott's Sturgis plant.

June 4

Abbott says it has reopened its baby formula production plant in Sturgis, Michigan.

June 6

United States organizes a flight to deliver 110,000 pounds of Nestlé infant formula from Germany to Texas on June 9.

June 10

White House says Delta Air Lines (NYSE:DAL) will start transporting 3.2 million bottles of Kendamil baby formula on June 20.

© Reuters. FILE PHOTO: Empty shelves show a shortage of baby formula at a Target store in San Antonio, Texas, U.S. May 10, 2022.  REUTERS/Kaylee Greenlee Beal/File Photo

June 15

Abbott stops production of EleCare specialty baby formula at its plant in southwestern Michigan after thunderstorms and heavy rains flooded parts of the facility.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.